30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Sandercock Colin

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sandercock Colin's trades of Cue Biopharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-08-07 2020-08-05
PlS Planned sale
97,318 -3.3%
129.88
US$3,708,978 		97,318 -3.3% 129.88 US$3,708,978
2020-08-05 2020-08-04
PlS Planned sale
10,083 -48.6%
59.62
US$768,068 		10,083 -48.6% 59.62 US$768,068
2020-08-05 2020-08-03
PlS Planned sale
40,373 -27.3%
402.04
US$875,085 		40,373 -27.3% 402.04 US$875,085
2019-06-10 2019-06-10
B Purchase
14,938 +746.9%
7.93
US$118,458 		14,938 +746.9% 7.93 US$118,458
2019-06-10 2019-06-06
B Purchase
2,000 +inf%
7.10
US$14,200 		2,000 +inf% 7.10 US$14,200